A Road to Nowhere: How the Biden NLRB Failed to Bury Ex-Cell-O

by | Mar 4, 2026 | Federal, General Counsel, Labor Relations Ink, Labor Relations Insight, Legal, News, NLRB, Trending

Under the NLRA, an employer that wants to challenge a union certification in court has a key mechanism to do so: To refuse to bargain while seeking judicial review. For over five decades, a 1970 decision, Ex-Cell-O, has protected that employer right while holding that “make-whole” remedies for doing so would “exceed the Board’s statutory powers.” It further followed that a suitable remedy would be an order to bargain, not a financial penalty.

Fast forward to 2021, and Biden-era NLRB General Counsel Jennifer Abruzzo felt differently, to put it mildly. The Board then intended to cement her guidance with a decision but ultimately failed to do so. This is a complicated subject, but let’s discuss where the current Board landed.

A Decision That Protected the Right to Fight

The Ex-Cell-O case began with a UAW election, which was contested by the employer, at an Indiana plant. The process of refusing to bargain generally triggers a ULP charge, which happened here.

Accordingly, the Board declined to punish the employer for exercising this legal right, and it rejected make-whole remedies. The decision also included an argument that such remedies would be “so speculative” that they’d amount to the “imposition of a penalty.”

Abruzzo’s Overreach and the Biden Board’s Shortfall

When Jennifer Abruzzo began her NLRB tenure in 2021, she issued memo GC 21-06, “Seeking Full Remedies,” in which she forecast her aggressive plan to expand remedies for ULP charges as defined under Section 8 of the NLRA. She specifically targeted Ex-Cell-O for reversal for “declining to provide a make-whole compensatory remedy for failures to bargain.”

Clearly, Abruzzo’s goal was to intimidate employers away from seeking judicial review of union certification by installing a cost-prohibitive penalty. The Board then proceeded to sever the Ex-Cell-O make-whole issue in multiple cases, including ArrMaz Products (2022) and Hudson Institute of Process Research (2023). Then came Longmont United Hospital, but the Biden Board never carried Ex-Cell-O to Abruzzo’s desired finish line.

The New Board Makes Its Move

The current Board and General Counsel Crystal Carey have made clear that Ex-Cell-O is preserved for the foreseeable future.

First, a Feb. 26 Board decision resolved the severed Longmont issue while Board members James Murphy and Scott Mayer declined to overrule Ex-Cell-O. In doing so, this two-member majority reached the same conclusion as the 1970 decision. They reasoned that make-whole remedies would not only obstruct employers from their legal right to judicial review but also, “It is hard to imagine a better recipe for hindering, rather than encouraging, the parties reaching agreement through collective bargaining.”

Next, General Counsel Crystal Carey confirmed in memo GC 26-03 that Ex-Cell-O sits among the cases that the NLRB “would no longer pursue” for reversal.

The End of the Ex-Cell-O Road, For Now

It should be noted that Murphy and Mayer recently found “no need at this time” to review existing precedent on Thryv make-whole remedies that might apply across a wide swath of ULP cases. That could change, but the Board has ensured that Ex-Cell-O stands intact and protects employers who refuse to bargain while seeking judicial review of union certification.

Of course, this could also change if the Board swings back to a more labor-friendly version, so employers should still seek legal counsel in these cases and keep their eyes open for future developments.

INK Newsletter

APPROACHABILITY MINUTE

The Left of Boom Show

GET OUR RETENTION TOOLKIT

PUBLICATIONS

Archives

Categories